LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 5500 | 5667 | 0.9704 | 0.9608 |
MCF7 | PIK-93 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 6076 | 5667 | 1.0720 | 1.0954 |
MCF7 | KIN001-043 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4942 | 5667 | 0.8720 | 0.8304 |
MCF7 | Alpelisib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 4433 | 5667 | 0.7822 | 0.7115 |
MCF7 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 1395 | 5667 | 0.2462 | 0.0015 |
MCF7 | A443654 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 1052 | 5667 | 0.1857 | -0.0786 |
MCF7 | OSI-027 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4017 | 5667 | 0.7087 | 0.6142 |
MCF7 | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4450 | 5667 | 0.7852 | 0.7154 |
MCF7 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 5981 | 5667 | 1.0554 | 1.0733 |
MCF7 | WH-4-025 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 3951 | 5667 | 0.6972 | 0.5989 |
MCF7 | WZ-4-145 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4235 | 5667 | 0.7473 | 0.6653 |
MCF7 | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 1767 | 5667 | 0.3118 | 0.0883 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 5251 | 5667 | 0.9265 | 0.9027 |
MCF7 | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 3825 | 5667 | 0.6749 | 0.5694 |
MCF7 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 5484 | 5667 | 0.9676 | 0.9571 |
MCF7 | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4810 | 5667 | 0.8487 | 0.7996 |
MCF7 | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 1389 | 5607 | 5667 | 0.9893 | 0.9858 |
MCF7 | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 1029 | 5667 | 0.1816 | -0.0840 |
MCF7 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 659 | 5667 | 0.1164 | -0.1705 |
MCF7 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4171 | 5667 | 0.7359 | 0.6502 |
MCF7 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 4654 | 5667 | 0.8211 | 0.7630 |
MCF7 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 6357 | 5667 | 1.1216 | 1.1610 |
MCF7 | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 4580 | 5667 | 0.8082 | 0.7459 |
MCF7 | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 5704 | 5667 | 1.0064 | 1.0084 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 1822 | 5667 | 0.3215 | 0.1012 |